217 related articles for article (PubMed ID: 31015254)
1. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
[TBL] [Abstract][Full Text] [Related]
2. A mouse model for inducible overexpression of Prdm14 results in rapid-onset and highly penetrant T-cell acute lymphoblastic leukemia (T-ALL).
Carofino BL; Ayanga B; Justice MJ
Dis Model Mech; 2013 Nov; 6(6):1494-506. PubMed ID: 24046360
[TBL] [Abstract][Full Text] [Related]
3. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.
Dettman EJ; Simko SJ; Ayanga B; Carofino BL; Margolin JF; Morse HC; Justice MJ
Oncogene; 2011 Jun; 30(25):2859-73. PubMed ID: 21339739
[TBL] [Abstract][Full Text] [Related]
4. Off to a Bad Start: Cancer Initiation by Pluripotency Regulator PRDM14.
Tracey LJ; Justice MJ
Trends Genet; 2019 Jul; 35(7):489-500. PubMed ID: 31130394
[TBL] [Abstract][Full Text] [Related]
5. PRDM14: a unique regulator for pluripotency and epigenetic reprogramming.
Nakaki F; Saitou M
Trends Biochem Sci; 2014 Jun; 39(6):289-98. PubMed ID: 24811060
[TBL] [Abstract][Full Text] [Related]
6.
Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
[TBL] [Abstract][Full Text] [Related]
7. ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance and primordial germ cell formation.
Nady N; Gupta A; Ma Z; Swigut T; Koide A; Koide S; Wysocka J
Elife; 2015 Nov; 4():e10150. PubMed ID: 26523391
[TBL] [Abstract][Full Text] [Related]
8. PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation.
Okashita N; Sakashita N; Ito K; Mitsuya A; Suwa Y; Seki Y
Biochem Biophys Res Commun; 2015 Oct; 466(1):138-45. PubMed ID: 26325469
[TBL] [Abstract][Full Text] [Related]
9. Co-option of the PRDM14-CBFA2T complex from motor neurons to pluripotent cells during vertebrate evolution.
Kawaguchi M; Sugiyama K; Matsubara K; Lin CY; Kuraku S; Hashimoto S; Suwa Y; Yong LW; Takino K; Higashida S; Kawamura D; Yu JK; Seki Y
Development; 2019 Jan; 146(2):. PubMed ID: 30630825
[TBL] [Abstract][Full Text] [Related]
10. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency.
Okashita N; Suwa Y; Nishimura O; Sakashita N; Kadota M; Nagamatsu G; Kawaguchi M; Kashida H; Nakajima A; Tachibana M; Seki Y
Stem Cell Reports; 2016 Dec; 7(6):1072-1086. PubMed ID: 27866876
[TBL] [Abstract][Full Text] [Related]
11. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase C increases Prdm14 level to promote self-renewal of embryonic stem cells through reducing Suv39h-induced H3K9 methylation.
Ji J; Cao J; Chen P; Huang R; Ye SD
J Biol Chem; 2024 Mar; 300(3):105714. PubMed ID: 38309502
[TBL] [Abstract][Full Text] [Related]
13. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL.
Carofino BL; Ayanga B; Tracey LJ; Brooke-Bisschop T; Justice MJ
Biol Open; 2016 May; 5(5):645-53. PubMed ID: 27106930
[TBL] [Abstract][Full Text] [Related]
14. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
[TBL] [Abstract][Full Text] [Related]
15. A critical role of PRDM14 in human primordial germ cell fate revealed by inducible degrons.
Sybirna A; Tang WWC; Pierson Smela M; Dietmann S; Gruhn WH; Brosh R; Surani MA
Nat Commun; 2020 Mar; 11(1):1282. PubMed ID: 32152282
[TBL] [Abstract][Full Text] [Related]
16. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
[TBL] [Abstract][Full Text] [Related]
17. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
18. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
[TBL] [Abstract][Full Text] [Related]
19. Co-repressor CBFA2T2 regulates pluripotency and germline development.
Tu S; Narendra V; Yamaji M; Vidal SE; Rojas LA; Wang X; Kim SY; Garcia BA; Tuschl T; Stadtfeld M; Reinberg D
Nature; 2016 Jun; 534(7607):387-90. PubMed ID: 27281218
[TBL] [Abstract][Full Text] [Related]
20. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
